Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Gilead Sciences
ClinicalTrials.gov Identifier:
NCT00743340
First received: August 26, 2008
Last updated: January 25, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)